Skip to Content


Filter by:



Second Opinion

Learn about policy issues important to medical schools and teaching hospitals, with Executive Vice President Atul Grover, M.D., Ph.D.

Washington Highlights

NIH Issues Statement Reiterating Ban on Funding Research Using Gene-Editing Technologies in Human Embryos

May 1, 2015—National Institutes of Health (NIH) Director Francis Collins, M.D., Ph.D., issued an April 29 statement affirming that the NIH will not fund any use of gene-editing technologies in human embryos.

Dr. Collins notes that “there are multiple existing legislative and regulatory prohibitions against this kind of work,” citing the Dickey-Wicker amendment (H.R. 2880), NIH Guidelines on recombinant DNA, and FDA regulations (21 CFR Part 312). The statement also clarifies that this ban does not apply to research projects studying genomic editing in other organisms, which the NIH currently funds. The statement closes, “NIH will continue to support a wide range of innovations in biomedical research, but will do so in a fashion that reflects well-established scientific and ethical principles.”

Contact:

Anurupa Dev, Ph.D.
Senior Science Policy Analyst
Telephone: 202-862-6048
Email: adev@aamc.org

.

envelope on a green background

Subscribe to Washington Highlights

RSS icon

Subscribe to RSS

Washington Highlights, a weekly electronic newsletter, features brief updates on the latest legislative and regulatory activities affecting medical schools and teaching hospitals.


Past Issues


For More Information

Jason Kleinman
Sr. Legislative Analyst, Govt. Relations
Telephone: 202-903-0806
Email: jkleinman@aamc.org